Antileishmanial activity of the violacein extracted from Chromobacterium violaceum [4]

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 3, 2001, Pages 449-450

  Leon, L L ^a   Miranda, C C ^a   De Souza, A O ^b,c   Duran N ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; DIMETHYL SULFOXIDE; PENTAMIDINE ISETHIONATE; UNCLASSIFIED DRUG; VIOLACEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; CELL COUNT; CELL SURVIVAL; CELL VIABILITY; CHROMOBACTERIUM; CHROMOBACTERIUM VIOLACEUM; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ISOLATION; INCUBATION TIME; LEISHMANIA; LETTER; LIVER TOXICITY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NEPHROTOXICITY; NONHUMAN; PROMASTIGOTE;

ANIMALS; ANTIPROTOZOAL AGENTS; CHROMOBACTERIUM; HUMANS; INDOLES; LEISHMANIA; PARASITIC SENSITIVITY TESTS;

EID: 0034812079     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Antigenic differences of Leishmania amazonensis isolates causing diffuse cutaneous leishmaniasis
2. Antigenic differences among Leishmania amazonensis isolates and their relationship with the clinical forms of the disease
3. Violacein cytotoxicity and induction of apoptosis in V-79 cells
4. Production, extraction and purification of violacein: An antibiotic pigment produced by Chromobacterium violaceum
5. Hemoflagellates - Commercially available liquid-media for rapid cultivation